Longitudinal Circulating Tumor DNA Profiling in Metastatic Colorectal Cancer During Anti-EGFR Therapy

BACKGROUND: Metastatic colorectal cancer (mCRC) is a heterogenous disease with limited precision medicine and targeted therapy options. Monoclonal antibodies against epidermal growth factor receptor (EGFR) have been a crucial treatment option for mCRC. However, proper biomarkers for predicting thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Wentao, Zou, Jianling, Li, Ye, Liu, Rujiao, Yan, Zhengqing, Chen, Shiqing, Zhao, Xiaoying, Guo, Weijian, Huang, Mingzhu, Li, Wenhua, Zhu, Xiaodong, Chen, Zhiyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908369/
https://www.ncbi.nlm.nih.gov/pubmed/35280779
http://dx.doi.org/10.3389/fonc.2022.830816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908369/
https://www.ncbi.nlm.nih.gov/pubmed/35280779
http://dx.doi.org/10.3389/fonc.2022.830816

Ejemplares similares